{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:34:38Z","timestamp":1791840878950,"version":"4.3.4"},"reference-count":51,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01223","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T00:13:50Z","timestamp":1506557630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice"],"prefix":"10.3389","volume":"8","author":[{"given":"Thomas","family":"Ebensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Debarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel K.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Blazejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Weissmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,9,28]]},"reference":[{"key":"B1","unstructured":"Fact Sheet No. 2112009"},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4161\/hv.7.0.14560","article-title":"Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine","volume":"7","author":"Durando","year":"2011","journal-title":"Hum Vaccin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0929-6646(09)60102-9","article-title":"Influenza pandemics: past, present and future","volume":"105","author":"Hsieh","year":"2006","journal-title":"J Formos Med Assoc"},{"key":"B4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1586\/14760584.2013.811178","article-title":"Clinical vaccine development for H5N1 influenza","volume":"12","author":"Clegg","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/507S20a","article-title":"Perspective: Ill prepared for a pandemic","volume":"507","author":"Stohr","year":"2014","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1473-3099(10)70157-2","article-title":"Needle-free influenza vaccination","volume":"10","author":"Amorij","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0169501","DOI":"10.1371\/journal.pone.0169501","article-title":"Intranasal immunization using mannatide as a novel adjuvant for an inactivated influenza vaccine and its adjuvant effect compared with MF59","volume":"12","author":"Ren","year":"2017","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.vaccine.2017.01.025","article-title":"Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge","volume":"35","author":"Moriyama","year":"2017","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/embor.2011.77","article-title":"c-di-AMP reports DNA integrity during sporulation in Bacillus subtilis","volume":"12","author":"Oppenheimer-Shaanan","year":"2011","journal-title":"EMBO Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrmicro3069","article-title":"Cyclic di-AMP: another second messenger enters the fray","volume":"11","author":"Corrigan","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/ni.2460","article-title":"The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response","volume":"13","author":"Parvatiyar","year":"2012","journal-title":"Nat Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e95728","DOI":"10.1371\/journal.pone.0095728","article-title":"The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages","volume":"9","author":"Skrnjug","year":"2014","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/embor.2013.132","article-title":"Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3 inflammasome","volume":"14","author":"Abdul-Sater","year":"2013","journal-title":"EMBO Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.vaccine.2009.12.045","article-title":"The member of the cyclic di-nucleotide family bis-(3\u2019, 5\u2019)-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant","volume":"28","author":"Libanova","year":"2010","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1016\/j.vaccine.2011.05.026","article-title":"Bis-(3\u2019,5\u2019)-cyclic dimeric adenosine monophosphate: strong Th1\/Th2\/Th17 promoting mucosal adjuvant","volume":"29","author":"Ebensen","year":"2011","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/irv.12056","article-title":"A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine","volume":"7","author":"Svindland","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e26973","DOI":"10.1371\/journal.pone.0026973","article-title":"Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP","volume":"6","author":"Pedersen","year":"2011","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1016\/j.vaccine.2011.04.094","article-title":"Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice","volume":"29","author":"Madhun","year":"2011","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e104824","DOI":"10.1371\/journal.pone.0104824","article-title":"Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge","volume":"9","author":"Sanchez","year":"2014","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jconrel.2015.03.017","article-title":"Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination","volume":"206","author":"Mittal","year":"2015","journal-title":"J Control Release"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1586\/14760584.2013.825445","article-title":"Adjuvanted influenza vaccines","volume":"12","author":"Even-Or","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"B25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4161\/hv.19568","article-title":"The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza","volume":"8","author":"Pedersen","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"B26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1398-9995.2004.00616.x","article-title":"Safety of sublingual immunotherapy with a monomeric allergoid in very young children","volume":"60","author":"Agostinis","year":"2005","journal-title":"Allergy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1586\/14760584.2013.811193","article-title":"Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults","volume":"12","author":"McElhaney","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"B28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1128\/JVI.01812-10","article-title":"T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model","volume":"85","author":"Guo","year":"2011","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/eji.201646723","article-title":"IL-17 and IL-22 in immunity: driving protection and pathology","volume":"47","author":"Eyerich","year":"2017","journal-title":"Eur J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1073\/pnas.0708684105","article-title":"Sublingual vaccination with influenza virus protects mice against lethal viral infection","volume":"105","author":"Song","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B34","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/mt.2010.222","article-title":"Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses","volume":"19","author":"Torrieri-Dramard","year":"2011","journal-title":"Mol Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1003905","DOI":"10.1371\/journal.ppat.1003905","article-title":"Tailored immune responses: novel effector helper T cell subsets in protective immunity","volume":"10","author":"Kara","year":"2014","journal-title":"PLoS Pathog"},{"key":"B36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2010.09.013","article-title":"Vaccination strategies to promote mucosal antibody responses","volume":"33","author":"Chen","year":"2010","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"F5","DOI":"10.1084\/jem.20011910","article-title":"Origin and homing of intestinal IgA antibody-secreting cells","volume":"195","author":"Lamm","year":"2002","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/mi.2010.8","article-title":"IL-10 production by CD4+ effector T cells: a mechanism for self-regulation","volume":"3","author":"Jankovic","year":"2010","journal-title":"Mucosal Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.4049\/jimmunol.0900657","article-title":"IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge","volume":"182","author":"McKinstry","year":"2009","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/cmi.2011.38","article-title":"A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection","volume":"8","author":"Wang","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/eji.200939260","article-title":"Th17: the ascent of a new effector T-cell subset. Preface","volume":"39","author":"Weaver","year":"2009","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/COH.0b013e328335c2f6","article-title":"Th17 cytokines in mucosal immunity and inflammation","volume":"5","author":"Guglani","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","article-title":"Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels","volume":"182","author":"Jaffar","year":"2009","journal-title":"J Immunol"},{"key":"B44","first-page":"919","article-title":"Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases","volume":"11","author":"Langridge","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"B45","doi-asserted-by":"publisher","first-page":"i92","DOI":"10.1136\/ard.2009.117101","article-title":"The pro and anti-inflammatory activities of immunoglobulin G","volume":"69","author":"Lux","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell\u2019s palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice","volume":"181","author":"Forbes","year":"2008","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1365-2249.2005.02779.x","article-title":"Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells","volume":"140","author":"Olas","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.0105-2896.2005.00290.x","article-title":"Mucosal immunoglobulins","volume":"206","author":"Woof","year":"2005","journal-title":"Immunol Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T00:13:51Z","timestamp":1506557631000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,28]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2017.01223"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01223","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,28]]},"article-number":"1223"}}